Skip to main content

Table 3 Results of chemotherapy

From: Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma

No. of patients

46

 

No. ATP-TCA directed courses

56

 

CR

12

(21%)

PR

21

(38%)

SD

6

(11%)

PD

15

(27%)

No. of patients not evaluable for response

2

(4%)

ORR

33

(59%)

Median PFS (months)

6.6

 

Median OAS (months)

10.4

Â